Ignoring Scientific Advice About Illegal Drugs In Favour Of Politically And Morally Motivated Judgements Wont Send The Right Signal To Young People
Main Category: Alcohol / Addiction / Illegal DrugsArticle Date: 20 Feb 2009 - 5:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Health Professional: | ![]() |
4.4 (5 votes) |
| Article Opinions: | 1 posts |
An Editorial in this week's Lancet discusses the decision of the UK home secretary Jacqui Smith to ignore expert advice to downgrade ecstasy. The recent report by the Advisory Council on the Misuse of Drugs concluded "that the harmfulness of MDMA to individuals and society more closely equates to drugs in class B and it should therefore be downgraded."
The Editorial concludes: "Why then did the Home Office veto this recommendation? Apparently, because it did not want to send a signal to young people that MDMA was being taken less seriously. Last year, the Home Secretary also overruled the ACMD's recommendation that cannabis should remain a class C drug rather than gain class B status. These ill-thought out decisions make a mockery of the ACMD and any attempt at a credible, evidence-based system for drug classification. Ignoring scientific advice about illegal drugs in favour of politically and morally motivated judgments will not send the right signal to young people. It will only undermine public health messages about all drugs, be it MDMA or more harmful legal substances such as tobacco and alcohol."
The Lancet
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





